Join to View Full Profile
21216 Northwest FwySte 650Cypress, TX 77429
Phone+1 281-955-9158
Fax+1 281-955-8720
Dr. Hust is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Michael Hust, MD, is a third generation Houstonian and seventh generation Texas. He is based in Cypress, TX, and specializes in cardiology with a subspecialty in interventional cardiology. He completed his residency in internal medicine at the University of Texas Health Science Center at Houston from 2016 to 2019 after graduating from Ross University School of Medicine in 2016. Thereafter, he continued to specialize in the field of general cardiology and further subspecialized into interventional cardiology, graduating in 2023. He is proud to "bring the knowledge and expertise of TMC" to the Greater Cypress, TX area.
Education & Training
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2016 - 2019
Ross University School of MedicineClass of 2016
Certifications & Licensure
TX State Medical License 2021 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- 1 citationsPrevalence and clinical characteristics of inappropriate myocardial perfusion imaging tests at a community hospitalNadia I. Abelhad, Kendall J. Kiser, Andres Hughes, Michael A. Hust, Enrique Garcia Sayan
BMJ Open Quality. 2019-07-01 - 1 citationsAdult cancer-related hemophagocytic lymphohistiocytosis - a challenging diagnosis: a case report.Michael A. Hust, Boris Blechacz, Diana L. Bonilla, Naval Daver, Cristhiam M. Rojas-Hernandez
Journal of Medical Case Reports. 2017-06-27
Press Mentions
COR-101 Is Inhibiting the Emerging “Indian” Variants of SARS-CoV-2 Including “Delta”July 16th, 2021
Lactobacilli Expressing Broadly Neutralizing Nanobodies Against HIV-1 as Potential Vectors for HIV-1 Prophylaxis?December 13th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
